ロード中...
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Glucagon-like peptide 1 (GLP-1) based therapy is an established treatment option for the management of type 2 diabetes mellitus (T2DM) and is recommended early in the treatment algorithm owing to glycaemic efficacy, weight reduction and favourable cardiovascular outcomes. Glucose-dependent insulinot...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7843845/ https://ncbi.nlm.nih.gov/pubmed/33325008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00981-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|